Researchers Synthesize Compounds For New Class Of Antibiotics

(Boston, Mass.) -- Researchers at Boston University and Scriptgen Pharmaceuticals, Inc., have successfully synthesized two compounds that open the door to the development of an entirely new class of antibiotics for use against today's increasingly drug-resistant bacteria as well as emerging forms of bacteria.

In a recent issue of the Journal of Organic Chemistry, the research team reported that they have chemically synthesized myxopyronin A and B, two natural compounds known to block replication of drug-resistant strains of bacteria. Before this breakthrough, the compounds could only be isolated from their bacterial source, a process that yielded quantities too small to be usable.

From a therapeutic standpoint, the compounds look particularly promising because of their selectivity. Harmful bacteria contain DNA-dependent polymerase enzymes, as do humans. Myxopyronin A and B attack the bacterial enzymes while leaving the human host alone.

In recent years, the incidence of infectious diseases has soared, along with deaths resulting from them. At the same time, the need for new antibiotics has risen steadily as bacteria have developed a resistance to existing drugs. The worldwide market for anti-infective drugs is now estimated to be $34 billion, and it is still growing.

"This is an exciting opportunity for the development of a new type of antibiotic," says James Panek, a professor of chemistry who led Boston University's participation in the project. "The chemical synthesis provides us with the means for generating the materials that can lead to new pharmaceuticals."

Scriptgen, a Waltham, MA, company that develops drugs to control the expression of genes, is now developing the processes for converting the raw materials of myxopyronin A and B into viable antibiotics.

"This is a significant breakthrough from a chemistry point of view, but it's the first step in the process, " said Michael G. Palfreym

Contact: Joan Schwartz
617 353-4626
Boston University

Page: 1 2

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. Researchers close in on breast cancer vaccine
4. Researchers discover link between insulin and Alzheimers
5. Researchers model brains electrical storm during a seizure
6. Researchers track programs success in curbing aggressive behavior
7. Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study
8. Researchers offer emergency workers a lifeline
9. Researchers discover genetic variant that may explain why women develop M.S. more than men
10. Researchers map the sexual network of an entire high school
11. Researchers hope monkeys can provide new insights into depression

Post Your Comments:

(Date:12/6/2019)... ... December 06, 2019 , ... Connecticut is home ... excellence in patient care. On December 12th, Hartford Business Journal will recognize eight ... Care Heroes Awards at the Hartford Marriott. , “We are fortunate to have ...
(Date:12/6/2019)... ... December 06, 2019 , ... Brain ... in Baltimore, Maryland at the AES Annual Meeting. The symposium, “Fundamentals of Quantitative ... Understand methods of quantitative sEMG analysis during ictal events;, 2. Review specific sEMG ...
(Date:12/5/2019)... Conn. (PRWEB) , ... December 05, 2019 , ... ... Physician Practice M&A: Risks and Rewards of Building Platforms— on Thursday, December 12, ... are competing for large, multi-specialty medical groups. Middle-market PE firms are scrambling to ...
(Date:12/4/2019)... ... December 04, 2019 , ... Now ... provides protection from disruptions to cells and tissue and inflammation that leads to ... Lag, is available in a dietary supplement product called Prepair™ . , ...
(Date:12/4/2019)... ... December 04, 2019 , ... Eolas Therapeutics Inc. today ... use and dependence. The study will investigate safety and pharmacokinetics (PK) of AZD4041 ... orexin-1 (hypocretin-1) receptors that is being developed in collaboration with AstraZeneca. , “Smoking-related ...
Breaking Medicine News(10 mins):
(Date:12/6/2019)... ... December 06, 2019 , ... In ... this month, Kenall is introducing the CSEDOIC luminaire series. CSEDOIC fixtures are designed ... requires the unpacking of hazardous drugs (HDs) and HD-active pharmaceutical ingredients from the ...
(Date:12/6/2019)... (PRWEB) , ... December 06, 2019 , ... ... distribution agreement with Forbidden Fruit Garden Supply LLC (a division of Horticultural Holdings ... discerning clientele of professional growers. , FFGS is a team of disciplined ...
(Date:12/4/2019)... ... 2019 , ... The Harm Reduction Institute (HRI) as a part of the ... rehab center and non-profit Intensive outpatient after care (IOP) , has officially ... distributed Naloxone amongst members of the own community in Orange County, CA. , ...
Breaking Medicine Technology:
Cached News: